Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Auspherix Ltd.

Latest From Auspherix Ltd.

Freshly Appointed Auspherix CEO Highlights New Antibiotic Class

Dr Neil Miller, the recently-appointed CEO of UK-based biotech Auspherix, talks to Scrip about the company's new class of antibiotics and how it plans to help address the worldwide antimicrobial resistance crisis.

Commercial Business Strategies

Start-Up Execs On The Move, January 2016

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Venture Funding Deals, July 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2015.

BioPharmaceutical Medical Device

Emergings In Brief, June 2015

Brief profiles of these recently formed companies: Auspherix, Medella Health, OmniSeq, and Xtuit Pharmaceuticals.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals